Amundi Regeneron Pharmaceuticals, Inc. Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Amundi holds 1,064,246 shares of REGN stock, worth $760 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

1,064,246

Previous 1,064,318 0.01%

Holding current value

$760 Million

Previous $1.12 Billion 0.01%

% of portfolio

0.42%

Previous 0.44%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $73,734 - $86,526	-72 Reduced 0.01%	1,064,246 $1.12 Billion
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $6.94 Million - $8.42 Million	7,859 Added 0.74%	1,064,318 $1.12 Billion
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $128 Million - $141 Million	142,334 Added 15.57%	1,056,459 $1.02 Billion
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $177 Million - $202 Million	228,839 Added 33.39%	914,125 $803 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $397,466 - $484,668	574 Added 0.08%	685,286 $564 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $61.3 Million - $72.7 Million	-87,503 Reduced 11.33%	684,712 $492 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $52.2 Million - $63.5 Million	76,780 Added 11.04%	772,215 $635 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $28.4 Million - $30.8 Million	40,245 Added 6.14%	695,435 $502 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $57.8 Million - $72.9 Million	100,682 Added 18.16%	655,190 $489 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $30.5 Million - $41.1 Million	55,578 Added 11.14%	554,508 $332 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $23 Million - $27 Million	38,600 Added 8.39%	498,930 $360 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $18.4 Million - $22.7 Million	33,873 Added 7.94%	460,330 $284 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $129 Million - $153 Million	225,038 Added 111.73%	426,457 $258 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $95.2 Million - $113 Million	201,419 New	201,419 $113 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account